Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CuriosityStream | CURI | Dec 24, 2024 | 1.53 | +1.32 |
Curis | CRIS | Dec 24, 2024 | 3.17 | -2.46 |
CURRENC Group | CURR | Dec 24, 2024 | 1.56 | -11.36 |
Curtiss-Wright | CW | Dec 24, 2024 | 361.27 | +1.63 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Dec 24, 2024 | 44.15 | +1.59 |
Cushman & Wakefield | CWK | Dec 24, 2024 | 13.38 | +0.83 |
Custom Truck One Source | CTOS | Dec 24, 2024 | 4.82 | +1.47 |
Customers Bancorp | CUBI | Dec 24, 2024 | 48.62 | +1.19 |
Customers Bancorp E Pref | CUBI-E | Dec 24, 2024 | 25.75 | -0.41 |
Customers Bancorp F Pref | CUBI-F | Dec 24, 2024 | 25.47 | -0.70 |
Cutera | CUTR | Dec 24, 2024 | 0.33 | -0.15 |
CVB Financial | CVBF | Dec 24, 2024 | 21.98 | +0.96 |
CVD Equipment | CVV | Dec 24, 2024 | 4.05 | +6.02 |
CVR Energy | CVI | Dec 24, 2024 | 18.16 | +0.44 |
Cvr Partners LP Unit | UAN | Dec 24, 2024 | 75.95 | +1.08 |
CVRx | CVRX | Dec 24, 2024 | 12.90 | +3.20 |
CVS Health | CVS | Dec 24, 2024 | 44.25 | +0.25 |
CXApp A | CXAI | Dec 24, 2024 | 1.57 | +1.29 |
CyberArk Software | CYBR | Dec 24, 2024 | 320.61 | +0.65 |
Cybin | CYBN | Dec 24, 2024 | 9.53 | -0.10 |
Cyclacel Pharmaceuticals | CYCC | Dec 24, 2024 | 0.32 | -2.40 |
Cyclacel Pharmaceuticals Pref | CYCCP | Dec 24, 2024 | 6.47 | 0.00 |
Cyclerion Therapeutics | CYCN | Dec 24, 2024 | 3.29 | +2.81 |
Cyclo Therapeutics | CYTH | Dec 24, 2024 | 0.60 | -1.13 |
Cyngn | CYN | Dec 24, 2024 | 0.60 | -14.84 |
Cytek Biosciences | CTKB | Dec 24, 2024 | 6.49 | +0.46 |
Cytokinetics | CYTK | Dec 24, 2024 | 48.53 | -0.86 |
Cytomed Therapeutics | GDTC | Dec 24, 2024 | 2.58 | +8.86 |
CytomX Therapeutics | CTMX | Dec 24, 2024 | 1.07 | -1.83 |
Cytosorbents | CTSO | Dec 24, 2024 | 0.89 | +6.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.